Imperial Oil Limited Common Stock vs State Street SPDR S&P Biotech ETF — how do they compare? Imperial Oil Limited Common Stock trades at $130.2 (market cap $62.22B), while State Street SPDR S&P Biotech ETF trades at $147.13 (market cap $10.27B). The key difference: Imperial Oil Limited Common Stock is far larger — about 6.1× State Street SPDR S&P Biotech ETF's market cap, and Imperial Oil Limited Common Stock pays a 1.9% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| IMO | XBI | |
|---|---|---|
Market Cap | $62.22B | $10.27B |
Volume | 560,544 | 9,751,587 |
Sector | Energy | Broad Market / Factor |
52-Week High | $138.33 | $169.55 |
52-Week Low | $83.72 | $107.32 |
Enterprise Value | $63.13B | — |
Dividend Yield | 1.9% | — |
Typical Hold Time | — | 39 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $146.8, down 3.04% today, with a bearish technical signal driven by selling pressure in moving averages. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts. Recent news highlights sector optimism from cancer vaccine breakthroughs and improved capital access, though the ETF carries higher volatility than diversified healthcare funds.
Outlook remains mixed with neutral analyst consensus but positive sector catalysts. Opportunities include biotech innovation and M&A potential, while risks involve high volatility, regulatory uncertainty, and expense ratios above broader healthcare ETFs. Investors should weigh targeted biotech exposure against sector-wide stability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Imperial Oil Limited is a Canadian integrated energy company that explores for and produces crude oil and natural gas, operates oil sands projects at Cold Lake, Kearl, and Syncrude, and refines and markets petroleum products under the Esso and Mobil brands. ExxonMobil Corporation holds a majority ownership stake in the company.
Read more on IMO →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →